
Dr James Duffy is a Director of Drug Discovery at the Medicines for Malaria Venture (MMV), a not-for-profit product development partnership (PDP) working to reduce the burden of malaria by discovering, developing and delivering new, effective and affordable antimalarial drugs. MMV has been partnering with the European Lead Factory (ELF) since 2018 to run high-throughput screens for novel antimalarials. We spoke with James about his experience of working with ELF, the importance of investing in early drug discovery, and the progress made to date with the MMV-ELF screening programmes.